EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

miRNA in the Progression of Diabetic Kidney Disease: New Insight

Zhiyue Zou, Ning Zhou iD, Chun Zhang iD

International Journal of Molecular Sciences · 31.12.2025 · 27 (1) · 420

DOI: 10.3390/ijms27010420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.12.2025. Verfasst von Zhiyue Zou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, MicroRNAs. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is a major microvascular complication of diabetes and a leading cause of end-stage renal disease worldwide. Despite advances in metabolic and blood pressure control, the prevalence of DKD continues to rise, creating a significant clinical and socioeconomic burden. Recent studies have revealed that non-coding RNAs, particularly microRNAs (miRNAs), play an important role in the development and progression of DKD. Distinct patterns of miRNA dysregulation have been identified in specific renal cell types, including podocytes, mesangial cells, tubular epithelial cells, endothelial cells, fibroblasts, and macrophages. These alterations drive characteristic cellular injuries such as podocyte loss, mesangial matrix expansion, tubular epithelial–mesenchymal transition, endothelial dysfunction, and interstitial fibrosis. Certain miRNAs, such as miR-21, miR-192, and miR-214, reinforce profibrotic TGF-β/Smad signaling, whereas protective groups, including the miR-29 and miR-30 families, maintain epithelial stability and restrict matrix deposition. Beyond their regulatory roles, circulating and urinary miRNAs have emerged as stable, non-invasive biomarkers that reflect renal injury and disease progression. This review summarizes recent progress in elucidating cell-specific miRNA networks in DKD and highlights their potential as diagnostic indicators and therapeutic targets for precision management of diabetic kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesMicroRNAsHumansDisease ProgressionAnimalsBiomarkersSignal TransductionGene Expression Regulation

Stichwörter der Autor:innen

biomarkerdiabetic kidney diseasemiRNA

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

ORCID-Profile: Ning Zhou, Chun Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zou, Z., Zhou, N., & Zhang, C. (2025). miRNA in the Progression of Diabetic Kidney Disease: New Insight. International Journal of Molecular Sciences, 27(1), 420. https://doi.org/10.3390/ijms27010420

Vancouver

Zou Z, Zhou N, Zhang C. miRNA in the Progression of Diabetic Kidney Disease: New Insight. International Journal of Molecular Sciences. 2025;27(1):420. doi:10.3390/ijms27010420

BibTeX
@article{Zou2025,
  author = {Zou, Zhiyue and Zhou, Ning and Zhang, Chun},
  title = {miRNA in the Progression of Diabetic Kidney Disease: New Insight},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {420},
  doi = {10.3390/ijms27010420}
}
Kostenlos starten →